Alligator Bioscience Announces Extraordinary General Meeting

• Alligator Bioscience will hold an extraordinary general meeting on November 27, 2026, to consider a smaller board and reduced fees.
• The nomination committee proposes three directors: Hans-Peter Ostler, Anna Törner and Søren Bregenholt, with Ostler remaining chairman.
• Proposed board fees would fall 30% to SEK 455,000 for the chairman and SEK 210,000 for each other nonemployee director.
• Reduced fees would apply pro rata from the extraordinary meeting until the next annual meeting; committee fees would remain unchanged.
• Bregenholt would receive no board or committee remuneration while remaining CEO through December 31, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alligator Bioscience AB published the original content used to generate this news brief on November 13, 2026, and is solely responsible for the information contained therein.